Additionally, mice only express DR5, therefore DR4+ regions also confirm the presence of human PC3 tumor cells.[65] DR5 expression for the combination treatment (25.6%) was similar to the PBS treatment (27.0%), and slightly higher compared to the FUS‐ or TRAIL‐only treatments (Figure 6G), consistent with the single treatment pilot study we performed (not shown). This evidence concerns the gene FUS and neoplasm.